Despite what the New York Times and its echoers have said, makers of innovative biologics have legitimate reason to sound alarms about automatic substitution of biosimilars that have not proven their interchangeability – and it’s not just because of the…
Tag Archives: New York Times
Don’t Call Them Generics!
January 29, 2013 – 4:19 pm
Extra! Extra! Leukemia Treatment Purposely Misses Holy Grail!
August 11, 2011 – 9:16 pm